Aemetis, Inc. (NASDAQ: AMTX) is a Basic Materials company (Chemicals - Specialty) with a market capitalization of $80M. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Aemetis, Inc. had a Maz Rating of 2.12 out of 5 (C, Hold), ranked against the other companies in its sector. Its strongest factor then was Valuation (4.14), more attractively valued than most of its sector; its weakest was Financial Health (1.09), among the weakest in its sector. The other factors: Growth 3.46 (around the middle of its sector); Profitability 2.30 (below most of its sector); Momentum 2.21 (below most of its sector). The current rating is for members: log in to see it.
At $1.09, Aemetis, Inc. trades at 0.3x sales, with an EV/EBITDA of 39.6. Over the last twelve months it generated about $264M of revenue and a net loss of $35M. It runs a gross margin of 20.6%, an operating margin of 6.9% and a net margin of -12.0%. It shows return on equity of 13.1%, return on invested capital of 5.2% and a free cash flow yield of -68.3%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 0.07. Over the past 52 weeks the share price ranged from $1.06 to $3.80, with a beta of 1.47.
Aemetis, Inc. does not currently pay a dividend.
7 Wall Street analyst ratings cover the stock: 5 Buy, 1 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.